The type III TGF-β receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation

Hye Jin You, Monique W. Bruinsma, Tam How, Julie H. Ostrander, Gerard C. Blobe

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Transforming growth factor β (TGFβ) has an important role as a negative regulator of cellular proliferation. The type III transforming growth factor β receptor (TβRIII) has an emerging role as both a TGFβ superfamily co-receptor and in mediating signaling through its cytoplasmic domain. In L6 myoblasts, TβRIII expression enhanced TGFβ1-mediated growth inhibition, with this effect mediated, in part, by the TβRIII cytoplasmic domain. The effects of TβRIII were not due to altered ligand presentation or to differences in Smad2 phosphorylation. Instead, TβRIII specifically increased Smad3 phosphorylation, both basal and TGFβ-stimulated Smad3 nuclear localization and Smad3-dependent activation of reporter genes independent of its cytoplasmic domain. Conversely, SB431542, a type I transforming growth factor β receptor (TβRI) inhibitor, as well as dominant-negative Smad3 specifically and significantly abrogated the effects of TβRIII on TGFβ1-mediated inhibition of proliferation. TβRIII also specifically increased p38 phosphorylation, and SB203580, a p38 kinase inhibitor, specifically and significantly abrogated the effects of TβRIII/TGFβ1-mediated inhibition of proliferation in L6 myoblasts and in primary human epithelial cells. Importantly, treatment with the TβRI and p38 inhibitors together had additive effects on abrogating TβRIII/ TGFβ1-mediated inhibition of proliferation. In a reciprocal manner, short hairpin RNA-mediated knockdown of endogenous TβRIII in various human epithelial cells attenuated TGFβ1-mediated inhibition of proliferation. Taken together, these data demonstrate that TβRIII contributes to and enhances TGFβ-mediated growth inhibition through both TβRI/Smad3-dependent and p38 mitogen-activated protein kinase pathways.

Original languageEnglish (US)
Pages (from-to)2491-2500
Number of pages10
JournalCarcinogenesis
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2007

Fingerprint

Growth Factor Receptors
MAP Kinase Signaling System
Transforming Growth Factors
p38 Mitogen-Activated Protein Kinases
Cell Proliferation
Myoblasts
Phosphorylation
Epithelial Cells
Growth
Reporter Genes
Small Interfering RNA
Phosphotransferases
Ligands

Cite this

The type III TGF-β receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. / You, Hye Jin; Bruinsma, Monique W.; How, Tam; Ostrander, Julie H.; Blobe, Gerard C.

In: Carcinogenesis, Vol. 28, No. 12, 01.12.2007, p. 2491-2500.

Research output: Contribution to journalArticle

@article{be07413d8e0743b8890c18b26de571a4,
title = "The type III TGF-β receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation",
abstract = "Transforming growth factor β (TGFβ) has an important role as a negative regulator of cellular proliferation. The type III transforming growth factor β receptor (TβRIII) has an emerging role as both a TGFβ superfamily co-receptor and in mediating signaling through its cytoplasmic domain. In L6 myoblasts, TβRIII expression enhanced TGFβ1-mediated growth inhibition, with this effect mediated, in part, by the TβRIII cytoplasmic domain. The effects of TβRIII were not due to altered ligand presentation or to differences in Smad2 phosphorylation. Instead, TβRIII specifically increased Smad3 phosphorylation, both basal and TGFβ-stimulated Smad3 nuclear localization and Smad3-dependent activation of reporter genes independent of its cytoplasmic domain. Conversely, SB431542, a type I transforming growth factor β receptor (TβRI) inhibitor, as well as dominant-negative Smad3 specifically and significantly abrogated the effects of TβRIII on TGFβ1-mediated inhibition of proliferation. TβRIII also specifically increased p38 phosphorylation, and SB203580, a p38 kinase inhibitor, specifically and significantly abrogated the effects of TβRIII/TGFβ1-mediated inhibition of proliferation in L6 myoblasts and in primary human epithelial cells. Importantly, treatment with the TβRI and p38 inhibitors together had additive effects on abrogating TβRIII/ TGFβ1-mediated inhibition of proliferation. In a reciprocal manner, short hairpin RNA-mediated knockdown of endogenous TβRIII in various human epithelial cells attenuated TGFβ1-mediated inhibition of proliferation. Taken together, these data demonstrate that TβRIII contributes to and enhances TGFβ-mediated growth inhibition through both TβRI/Smad3-dependent and p38 mitogen-activated protein kinase pathways.",
author = "You, {Hye Jin} and Bruinsma, {Monique W.} and Tam How and Ostrander, {Julie H.} and Blobe, {Gerard C.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1093/carcin/bgm195",
language = "English (US)",
volume = "28",
pages = "2491--2500",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - The type III TGF-β receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation

AU - You, Hye Jin

AU - Bruinsma, Monique W.

AU - How, Tam

AU - Ostrander, Julie H.

AU - Blobe, Gerard C.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Transforming growth factor β (TGFβ) has an important role as a negative regulator of cellular proliferation. The type III transforming growth factor β receptor (TβRIII) has an emerging role as both a TGFβ superfamily co-receptor and in mediating signaling through its cytoplasmic domain. In L6 myoblasts, TβRIII expression enhanced TGFβ1-mediated growth inhibition, with this effect mediated, in part, by the TβRIII cytoplasmic domain. The effects of TβRIII were not due to altered ligand presentation or to differences in Smad2 phosphorylation. Instead, TβRIII specifically increased Smad3 phosphorylation, both basal and TGFβ-stimulated Smad3 nuclear localization and Smad3-dependent activation of reporter genes independent of its cytoplasmic domain. Conversely, SB431542, a type I transforming growth factor β receptor (TβRI) inhibitor, as well as dominant-negative Smad3 specifically and significantly abrogated the effects of TβRIII on TGFβ1-mediated inhibition of proliferation. TβRIII also specifically increased p38 phosphorylation, and SB203580, a p38 kinase inhibitor, specifically and significantly abrogated the effects of TβRIII/TGFβ1-mediated inhibition of proliferation in L6 myoblasts and in primary human epithelial cells. Importantly, treatment with the TβRI and p38 inhibitors together had additive effects on abrogating TβRIII/ TGFβ1-mediated inhibition of proliferation. In a reciprocal manner, short hairpin RNA-mediated knockdown of endogenous TβRIII in various human epithelial cells attenuated TGFβ1-mediated inhibition of proliferation. Taken together, these data demonstrate that TβRIII contributes to and enhances TGFβ-mediated growth inhibition through both TβRI/Smad3-dependent and p38 mitogen-activated protein kinase pathways.

AB - Transforming growth factor β (TGFβ) has an important role as a negative regulator of cellular proliferation. The type III transforming growth factor β receptor (TβRIII) has an emerging role as both a TGFβ superfamily co-receptor and in mediating signaling through its cytoplasmic domain. In L6 myoblasts, TβRIII expression enhanced TGFβ1-mediated growth inhibition, with this effect mediated, in part, by the TβRIII cytoplasmic domain. The effects of TβRIII were not due to altered ligand presentation or to differences in Smad2 phosphorylation. Instead, TβRIII specifically increased Smad3 phosphorylation, both basal and TGFβ-stimulated Smad3 nuclear localization and Smad3-dependent activation of reporter genes independent of its cytoplasmic domain. Conversely, SB431542, a type I transforming growth factor β receptor (TβRI) inhibitor, as well as dominant-negative Smad3 specifically and significantly abrogated the effects of TβRIII on TGFβ1-mediated inhibition of proliferation. TβRIII also specifically increased p38 phosphorylation, and SB203580, a p38 kinase inhibitor, specifically and significantly abrogated the effects of TβRIII/TGFβ1-mediated inhibition of proliferation in L6 myoblasts and in primary human epithelial cells. Importantly, treatment with the TβRI and p38 inhibitors together had additive effects on abrogating TβRIII/ TGFβ1-mediated inhibition of proliferation. In a reciprocal manner, short hairpin RNA-mediated knockdown of endogenous TβRIII in various human epithelial cells attenuated TGFβ1-mediated inhibition of proliferation. Taken together, these data demonstrate that TβRIII contributes to and enhances TGFβ-mediated growth inhibition through both TβRI/Smad3-dependent and p38 mitogen-activated protein kinase pathways.

UR - http://www.scopus.com/inward/record.url?scp=36949015426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36949015426&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgm195

DO - 10.1093/carcin/bgm195

M3 - Article

C2 - 17768179

AN - SCOPUS:36949015426

VL - 28

SP - 2491

EP - 2500

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 12

ER -